Mainz
Germany
76
2021-06-03
The entities that hold a legal rights for patent applications filed by inventor Hess Georg:
Georg Hess from Mainz, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure
#2 | 2020-10-22NT-proANP AND NT-proBNP FOR THE DIAGNOSIS OF STROKE
#3 | 2020-06-25GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients
#4 | 2020-02-27Use of IGFBP-7 in the assessment of heart failure
#5 | 2018-07-12Troponin and BNP based diagnosis of risk patients and cause of stroke
#6 | 2017-09-14NT-pro ANP and SFlt-1 For The Differentiation Between Circulatory And Ischemic Events
#7 | 2017-03-23PREDICTION AND RECOGNITION OF ACUTE KIDNEY INJURY AFTER SURGERY
#8 | 2017-01-26TROPONIN AND BNP BASED DIAGNOSIS OF RISK PATIENTS AND CAUSE OF STROKE
#9 | 2017-01-19Use of IGFBP-7 in the assessment of heart failure
#10 | 2016-05-26USE OF ALPHA-CRYSTALLIN B (CRYAB) IN THE ASSESSMENT OF HEART FAILURE
#11 | 2016-01-14TROPONIN AND BNP BASED DIAGNOSIS OF RISK PATIENTS AND CAUSE OF STROKE
#12 | 2015-10-15USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE
#13 | 2015-03-19Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
#14 | 2014-09-18NT-proANP and NT-proBNP for the diagnosis of stroke
#15 | 2014-08-07TROPONIN AND BNP BASED DIAGNOSIS OF RISK PATIENTS AND CAUSE OF STROKE
#16 | 2014-07-10USE OF SFRP-3 IN THE ASSESSMENT OF HEART FAILURE
#17 | 2014-03-06USE OF BIOMARKERS IN THE ASSESSMENT OF THE EARLY TRANSITION FROM ARTERIAL HYPERTENSION TO HEART FAILURE
#18 | 2013-05-16Prediction and recognition of acute kidney injury after surgery
#19 | 2013-03-21GDF-15 BASED MEANS AND METHODS FOR SURVIVAL AND RECOVERY PREDICTION IN ACUTE INFLAMMATION
#20 | 2012-10-18Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction
#21 | 2012-10-04GDF-15 and/or Troponin T for Predicting Kidney Failure in Heart Surgery Patients
#22 | 2012-08-23NT-pro ANP and SFlt-1 for the differentiation between circulatory and ischemic events
#23 | 2012-06-28MARKER PANEL FOR LEFT VENTRICULAR HYPERTROPHY
#24 | 2012-06-21Use of mimecan in the assessment of heart failure
#25 | 2012-02-02METHODS FOR DIAGNOSING KIDNEY DAMAGE ASSOCIATED WITH HEART FAILURE
#26 | 2012-01-12DIFFERENTIATING CARDIAC- AND DIABETES MELLITUS-BASED CAUSES OF KIDNEY DAMAGE
#27 | 2011-10-27DIFFERENTIATING BETWEEN FIBROSIS AND CIRRHOSIS
#28 | 2011-10-20METHOD FOR ASSESSMENT OF SEVERITY OF LIVER CIRRHOSIS
#29 | 2011-09-22USE OF CARDIAC HORMONES TO ASSESS RISK OF CARDIOVASCULAR COMPLICATION FROM VOLUME OVERLOAD
#30 | 2011-09-01Monitoring myocardial infarction and its treatment
#31 | 2011-08-25PREDICTING CARDIOVASCULAR EVENTS AND RENAL FAILURE IN TYPE 1 DIABETICS
#32 | 2011-07-07USE OF BIGLYCAN IN THE ASSESSMENT OF HEART FAILURE
#33 | 2011-06-30NATRIURETIC PEPTIDES AND ADIPONECTIN IN SUBJECTS WITH A METABOLIC SYNDROME
#34 | 2011-05-19USING CARDIAC TROPONIN FOR MONITORING ANTI-ANGIOGENESIS THERAPY
#35 | 2011-05-19Identification of subjects being susceptible to anti-angiogenesis therapy
#36 | 2011-05-12MULTIMARKER PANEL FOR DIFFERENTIATION OF DILATED CARDIOMYOPATHY AND AS A BASIS FOR DIFFERENTIAL THERAPY
#37 | 2011-05-12MULTIMARKER PANEL FOR MONITORING PATIENTS WITH AND WITHOUT OVERT HEART FAILURE
#38 | 2011-04-07MEANS AND METHODS FOR DETERMINING THE ARTERIOSCLEROTIC STENOSIS USING INFLAMMATORY BIOMARKERS
#39 | 2011-04-07ASSESSMENT OF COMPLICATIONS OF PATIENTS WITH TYPE 1 DIABETES
#40 | 2011-04-07VASCULAR MARKERS IN THE REMODELING OF CARDIAC INJURY
#41 | 2011-03-31H-FABP AS A MARKER FOR MYOCARDIAL HIBERNATION
#42 | 2011-03-10IDENTIFYING SUSCEPTIBILITY OF A SUBJECT TO CARDIAC THERAPY BASED ON DETERMINATION OF A CARDIAC TROPONIN, SCD40L, AND C-REACTIVE PROTEIN
#43 | 2011-03-10L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy
#44 | 2011-03-03METHOD FOR RISK REDUCTION IN GLYCEMIC CONTROL
#45 | 2011-02-10Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1
#46 | 2011-02-10RISK ANALYSIS IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROME
#47 | 2011-02-10GDF-15 AS BIOMARKER IN TYPE 1 DIABETES
#48 | 2011-02-03Use of SFRP-3 in the assessment of heart failure
#49 | 2010-11-11Myoglobin as early predictor of myocardial infarction
#50 | 2010-11-11Use of SLIM-1 in the assessment of heart failure
#51 | 2010-11-11USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE
#52 | 2010-10-28DETERMINING ATHEROSCLEROTIC LOAD USING PLACENTAL GROWTH FACTOR
#53 | 2010-10-07NT-proBNP/troponin ratio for assessing myocardial dysfunction
#54 | 2010-09-30DETECTION OF CONTRAST MEDIUM-INDUCED NEPHROTOXICITY
#55 | 2010-09-30DIFFERENTIATION OF CAUSES OF RIGHT HEART FAILURE
#56 | 2010-08-12Biochemical markers for acute pulmonary embolism
#57 | 2010-07-01ASSESSING RISK OF CARDIAC INTERVENTION IN PATIENTS SUFFERING FROM STABLE CORONARY HEART DISEASE BASED ON GDF-15
#58 | 2010-06-24Assessing heart failure in patients with atrial fibrillation using GDF-15 and natriuretic peptides
#59 | 2010-06-24H-FABP as early predictor of myocardial infarction
#60 | 2010-04-08PLGF, FLT1 AND ENDOGLIN FOR DIAGNOSING ANGIOGENIC STATUS IN CORONARY ARTERY DISEASE
#61 | 2010-04-01Biochemical markers for acute pulmonary embolism
#62 | 2010-03-25Diagnostic means and methods using troponin T and NT-proBNP
#63 | 2009-04-30Methods for differentiation between cardiac and pulmonary causes of chronic dyspnea
#64 | 2009-04-02Differentiation of acute and chronic myocardial necrosis in symptomatic patients
#65 | 2009-03-26Biochemical markers for acute pulmonary embolism
#66 | 2009-03-26DISCRIMINATON OF CARDIAC DYSFUNCTION IN PREGNANT FEMALES
#67 | 2009-02-19Natriuretic peptides and placenta growth factor levels for risk stratification
#68 | 2009-02-12NT-proANP and NT-proBNP for diagnosing cardiac diseases
#69 | 2008-07-17NATRIURETIC PEPTIDE RATIO FOR DIAGNOSING CARDIAC DYSFUNCTIONS
#70 | 2008-04-03Cardiac troponin as an indicator of coronary artery disease
#71 | 2008-03-20Differentiation of cardiac and pulmonary causes of acute shortness of breath
#72 | 2007-08-16Diagnosing risk of cardiovascular complications using natiuretic peptides
#73 | 2007-01-18Multimarker panel for diabetes type 1 and 2
#74 | 2006-01-26Multimarker panel for diabetes type 1 and 2
#75 | 2006-01-12Multimarker panel based on PIGF for diabetes types 1 and 2
#76 | 2005-10-27Use of cardiac hormones to assess risk of cardiovascular complication from volume overload
153241 ⎘